WebThe dose of cisplatin and paclitaxel was selected at the original IC 50 concentration of each drug for each cell line, as well as the dose after reduction according to the … WebJul 31, 2014 · Paclitaxel (PTX) and/or cisplatin (CDDP), as important cytotoxic anti-cancer agents, are widely used to treat various solid tumors. Both may cause moderate or severe neurotoxicity, but ocular neurotoxicity is also occasionally reported. A patient diagnosed with nasopharyngeal cancer suffering acute ocular neurotoxicity 10 days after paclitaxel ...
Cisplatin + Taxol - Navigating Care
WebIn the ECOG1395 study, in which Paclitaxel-Cisplatin treatment was evaluated in patients with Head and Neck Cancer, grade 3 and higher neurotoxicity was detected in 8% of the patients (2). In addition, it has been reported that 70% of the patients develop Grade 1-2 neuropathy and 6% Grade 3 neuropathy with the combination of six courses of ... WebJan 24, 2011 · Drugs used in chemotherapy, such as paclitaxel and cisplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Veliparib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. curved infrared massager
Current Oncology Free Full-Text Blockade of ALDH in Cisplatin ...
WebOct 8, 2001 · The combination of ifosfamide, paclitaxel, and cisplatin is a well-tolerated outpatient regimen with significant activity in the treatment of newly diagnosed FIGO Stage III or IV epithelial ovarian carcinoma. Further evaluation is justified to clearly define the role of ifosfamide as an additional agent to the current platinum and paclitaxel ... WebJan 2, 1998 · The first large, randomized study of paclitaxel/carboplatin for advanced or metastatic non-small-cell lung cancer compared this combination with the standard cisplatin/etoposide regimen (Table 5). The study accrued 369 patients over 15 months. The median survival is 8.25 months, and the 1-year survival is 35%. WebPatients who underwent primary and interval cytoreduction received a single dose of IP chemotherapy for 24 hours after being divided into four groups: group A, IP cisplatin; group B, IP paclitaxel; group C, IP paclitaxel and cisplatin; and group D, saline. Pre- and postperitoneal IP cytology was assessed along with possible complications. curved insulated roof panels